Estudos Randomizados
Estudo randomizado | Eficácia e segurança do somatrogom semanal vs. somatropina diária em crianças com deficiência do hormônio do crescimento.
14 Abr, 2022 | 16:34hEstudo randomizado | Peneiclidina inalatória profilática para prevenção de complicações pulmonares pós-operatórias em pacientes de alto risco.
14 Abr, 2022 | 16:22hEstudo randomizado | Para adultos vivendo com HIV, uma estratégia de tratamento de 4-dias-sim e 3-dias-não é não inferior ao tratamento padrão para manter a supressão viral.
12 Abr, 2022 | 12:45hA 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial – The Lancet HIV (link para o resumo – $ para o texto completo)
Comentário: Intermittent Treatment Strategy Is Effective for HIV – Consultant360
Comentário no Twitter
New: A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial by Roland Landman and colleagues https://t.co/Tc2Rbo1ISt pic.twitter.com/YTV3XwfELo
— The Lancet HIV (@TheLancetHIV) February 3, 2022
In virologically suppressed people with HIV, randomization to intermittent ART (4 days on, 3 off) was non-inf. to daily dosing. Challenges what I thought about level of adherence needed. Is good adherence only needed during the viremic phase? https://t.co/lM8QZW0C9h
— David Serota (@serotavirus) March 16, 2022
Estudo randomizado | Eficácia e segurança do gefapixante, um antagonista donreceptor de P2X3, na tosse crônica refratária e na tosse crônica inexplicada.
12 Abr, 2022 | 12:17hEfficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials – The Lancet (link para o resumo – $ para o texto completo)
Comentário no Twitter
For refractory chronic cough or unexplained chronic cough, gefapixant 45 mg twice per day is the first treatment to show efficacy with an acceptable safety profile in phase 3 clinical trials.
New study by Lorcan P McGarvey & colleagues: https://t.co/XnWM75s6lN pic.twitter.com/VyYyRgWTod
— The Lancet (@TheLancet) March 7, 2022
Comentário de estudo | Bougie vs. Stylet para entubação bem-sucedida na primeira passagem.
11 Abr, 2022 | 12:41hComentário de estudo | Glaucoma avançado: cirurgia para reduzir a pressão no olho é mais efetiva do que colírios.
11 Abr, 2022 | 12:40hEstudo randomizado | Entre pacientes com infecção complicada de trato urinário, o uso oral de tebipenem pivoxil hidrobromida foi não inferior ao ertapenem intravenoso e mostrou perfil de segurança similar.
8 Abr, 2022 | 21:50hOral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection – New England Journal of Medicine (link para o resumo – $ para o texto completo)
Comentário no Twitter
For complicated UTI or acute pyelonephritis, oral tebipenem pivoxil hydrobromide noninferior to IV ertapenem and has a similar safety profile. https://t.co/FRDMQOD0Pn pic.twitter.com/GFQz7SlciX
— NEJM (@NEJM) April 6, 2022
Estudo randomizado | Eficácia de longo prazo e segurança da denervação renal na presença de medicamentos anti-hipertensivos.
8 Abr, 2022 | 21:47hLong-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial – The Lancet (link para o resumo – $ para o texto completo)
Comentário: Three-year trial of SPYRAL HTN-ON MED shows blood pressure reductions – MedicalXpress
Conteúdos relacionados:
Comentário no Twitter
Renal denervation could provide an adjunctive treatment modality in the management of patients with #hypertension, suggests trial assessing long-term efficacy & safety in the presence of antihypertensive drugs: https://t.co/45ojbyhQp3 pic.twitter.com/eg6CXGDGCE
— The Lancet (@TheLancet) April 6, 2022
Estudo randomizado | Efeito de diferentes esquemas de doses de corticosteroides sobre os desfechos clínicos em meninos com distrofia muscular de Duchenne.
8 Abr, 2022 | 21:46hEffect of Different Corticosteroid Dosing Regimens on Clinical Outcomes in Boys With Duchenne Muscular Dystrophy: A Randomized Clinical Trial – JAMA (gratuito por tempo limitado)
Conteúdos relacionados:
RCT: Routine lung volume recruitment is not beneficial for boys with Duchenne muscular dystrophy.
Research: Long-term effects of glucocorticoids in patients with Duchenne muscular dystrophy
Comentário no Twitter
In this randomized clinical trial of boys with Duchenne muscular dystrophy, treatment with daily or daily #deflazacort resulted in significantly better outcomes compared with intermittent prednisone. https://t.co/rKjSrjVemR #AAN2022 pic.twitter.com/qPNV9KBOXv
— JAMA (@JAMA_current) April 5, 2022
Estudo randomizado | Efetividade clínica de injeção intra-articular guiada por ultrassonografia com corticosteroide e anestésico local para a osteoartrite de quadril.
8 Abr, 2022 | 21:39hComunicado de imprensa: Steroid injections may provide longer lasting benefits for hip pain than current best care – BMJ
Comentário no Twitter
Adding an ultrasound guided corticosteroid and local anaesthetic injection to advice and education offers rapid and sustained improvements in pain and function, finds new research https://t.co/fQHzvKv2wL
— The BMJ (@bmj_latest) April 7, 2022


